Arvee Laboratories (India) shareholding pattern

ARVEE

154

5.26 (-3.30%)
Last updated on 25 Feb, 2026 | 09:22 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Arvee Laboratories (India) Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

73.5%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

26.5%

Others

0%

Total Promoters
MAR '24
73.5%
JUN '24
73.5%
SEP '24
73.5%
DEC '24
73.5%

Summary

For Year 2025-26, Arvee Laboratories (India) reports the following shareholding: Total Promoters at 73.51%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 26.49%. This breakdown provides a quick snapshot of ownership distribution for Arvee Laboratories (India) in 2025-26.

Arvee Laboratories (India) FAQs

As of 02-2026, the promoter shareholding in Arvee Laboratories (India) stands at 73.51% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Arvee Laboratories (India) is 0% and 0% respectively.

The retail shareholding of the Arvee Laboratories (India) is 26.49%.

Changes in shareholding patterns of Arvee Laboratories (India) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Arvee Laboratories (India) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost